Role of CD28 in the generation of effector and memory responses required for resistance to Toxoplasma gondii

Journal of Immunology

Volumn 163, Issue 6, 1999, Pages 3344-3353

  Villegas, Eric N ^a   Elloso, M Merle ^a   Reichmann, Gaby ^a,c   Peach, Robert ^b   Hunter, Christopher A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD45 ANTIGEN; HERMES ANTIGEN; INTERLEUKIN 2; PADGEM PROTEIN; PARASITE ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION RESISTANCE; MALE; MEMORY CELL; MOUSE; NONHUMAN; PARASITE IMMUNITY; PHENOTYPE; PRIORITY JOURNAL; STRAIN DIFFERENCE; TOXOPLASMA GONDII;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD80; CHRONIC DISEASE; FEMALE; IMMUNITY, NATURAL; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; T-LYMPHOCYTE SUBSETS; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VIRULENCE;

EID: 0033568716     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
2. Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104.
3. Sharpe, A. H. 1995. Analysis of lymphocyte costimulation in vivo using transgenic and 'knockout' mice. Curr. Opin. Immunol. 7:389.
4. Green, J. M., P. J. Noel, A. I. Sperling, T. L. Walunas, D. J. Lenschow, R. Stack, G. S. Gray, J. A. Bluestone, and C. B. Thompson. 1995. T cell costimulation through the CD28 receptor. Proc. Assoc. Am. Physicians 107:41.
5. Miller, S. D., C. L. Vanderlugt, D. J. Lenschow, J. G. Pope, N. J. Karandikar, M. C. Dal Canto, and J. A. Bluestone. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3:739.
6. Linsley, P. S., P. M. Wallace, J. Johnson, M. G. Gibson, J. L. Greene, J. A. Ledbetter, C. Singh, and M.A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257:792.
7. Herold, K. C., V. Vezys, A. Koons, D. Lenschow, C. Thompson, and J. A. Bluestone. 1997. CD28/B7 costimulation regulates autoimmune diabetes induced with multiple low doses of streptozotocin. J. Immunol. 158:984.
8. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145.
9. Keane-Myers, A., W. C. Gause, P. S. Linsley, S.-J. Chen, and M. Wills-Karp. 1997. B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J. Immunol. 158:2042.
10. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609.
11. - T cells: B7-independent costimulation of CD1-restricted T cells. J. Exp. Med. 182:2007.
12. Johnson, J. G., and M. C. Jenkins. 1994. Monocytes provide a novel costimulatory signal to T cells that is not mediated by the CD28/B7 interaction. J. Immunol. 152:429.
13. Croft, M., L. M. Bradley, and S. L. Swain. 1994. Naive versus memory CD4 T cell response to antigen: memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol. 152:2675.
14. Schweitzer, A. N., and A. H. Sharpe. 1998. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. J. Immunol. 161:2762.
15. Corry, D. B., S. L. Reiner, P. S. Linsley, and R. M. Locksley. 1994. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J. Immunol. 153:4142.
16. Brown, D. R., J. M. Green, N. H. Moskowitz, M. Davis, C. B. Thompson, and S. L. Reiner. 1996. Limited role of CD28-mediated signals in T helper subset differentiation. J. Exp. Med. 184:803.
17. Gause, W. C., S. J. Chen, R. J. Greenwald, M. J. Halvorson, P. Lu, X. di Zhou, S. C. Morris, K. P. Lee, C. H. June, F. D. Finkelman, J. F. Urban, and R. Abe. 1997. CD28 dependence of T cell differentiation to IL-4 production varies with the particular type 2 immune response. J. Immunol. 158:4082.
18. Kundig, T. M., A. Shahinian, K. Kawai, H.-W. Mittrucker, E. Sebzda, M. F. Bachmann, T. W. Mak, and P. S. Ohashi. 1996. Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 5:41.
19. King, C. L., J. Xianli, C. H. June, R. Abe, and K. P. Lee. 1996. CD28-deficient mice generate an impaired Th2 response to Schistosoma mansoni infection. Eur. J. Immunol. 26:2448.
20. Liu, Y., R. H. Wenger, M. Zhao, and P. J. Nielsen. 1997. Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. J. Exp. Med. 185:251.
21. Gause, W. C., V. Mitro, C. Via, P. Linsley, J. F. Urban, and R. J. Greenwald. 1997. Do effector and memory T helper cells also need B7 ligand costimulatory signals? J. Immunol. 159:1055.
22. Wong, S.-Y., and J. S. Remington. 1994. Toxoplasmosis in the setting of AIDS. In Textbook of AIDS Medicine. S. Broder, T. C. J. Merigan, and D. Bolognesi, eds. Williams and Wilkins, Baltimore, MD, p. 223.
23. Suzuki, Y., M. A. Orelana, R. D. Schreiber, and J. S. Remington. 1988. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240:516.
24. + T lymphocytes is required to reactivate chronic infections with Toxoplasma gondii. J. Immunol. 149:175.
25. + T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 146:286.
26. +, L3T4 T cells in mice. J. Immunol. 140:3943.
27. Hunter, C. A., L. Ellis-Neyer, K. Gabriel, M. Kennedy, P. Linsley, and J. S. Remington. 1997. The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii. J. Immunol. 158: 2285.
28. Subauste, C. S., R. de Waal Malefyt, and F. Fuh. 1998. Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen. J. Immunol. 160:1831.
29. Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283.
30. Sharma, S. D., J. Mullenax, F. G. Araujo, A. A. Erlich, and J. S. Remington. 1983. Western blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies. J. Immunol. 131:977.
31. Conley, F. K., and Jenkins, K. A. 1981. Immunohistological study of the anatomic relationship of toxoplasma antigens to the inflammatory response in the brains of mice chronically infected with Toxoplasma gondii. Infect. Immun. 31: 1184.
32. Abrams, J. S., M. G. Roncarolo, H. Yssel, G. J. Andersson, and J. E. Silver. 1992. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127:5.
33. Sander, B., I. Hoiden, U. Andersson, E. Moller, and J. S. Abrams. 1993. Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. J. Immunol. Methods 166:201.
34. Hunter, C. A., C. S. Subauste, V. H. Van Cleave, and J. S. Remington. 1994. Production of γ interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor α. Infect. Immun. 62:2818.
35. Suzuki, Y., M. A. Orellana, S. Y. Wong, F. K. Conley, and J. S. Remington. 1993. Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection in mice. Infect. Immun. 61:2284.
36. Khan, I. A., T. Matsuura, and L. H. Kasper. 1994. Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect. Immun. 62:1639.
37. Gazzinelli, R. T., M. Wysocka, S. Hayashi, E. Y. Denkers, S. Hieny, P. Caspar, G. Trinchieri, and A. Sher. 1994. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533.
38. van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand-transduced costimulation of T cells in the development of helper function. Nature 378:620.
39. - T lymphocytes by 4-1BB ligand. J. Immunol. 158:551.
40. Peng, X., A. Kasran, P. A. Warmerdam, M. de Boer, and J. L. Ceuppens. 1996. Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-γ production. Eur. J. Immunol. 26:1621.
41. Kamanaka, M., P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275.
42. Soong, L., J.-C. Xu, I.S. Grewa, P. Kima, J. Sun, B. J. Longley, N. H. Ruddle, D. McMahon-Pratt, and R. A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4:263.
43. Yashiro, Y., X.-G. Tai, K. Toyo-oka, C.-S. Park, R. Abe, T. Hamaoka, M. Kobayashi, S. Neben, and H. Fujiwara. 1998. A fundamental difference in the capacity to induce proliferation of naive T cells between CD28 and other costimulatory molecules. Eur. J. Immunol. 28:926.
44. Guo, Y., Y. Wu, S. Shinde, M-S. Sy, A. Aruffo, and Y. Liu. 1996. Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. J. Exp. Med. 184:955.
45. Wu, Y., Q. Zhou, P. Zheng, and Y. Liu. 1998. CD28-independent induction of T helper cells and immunoglobulin class switches requires costimulation by the heat-stable antigen. J. Exp. Med. 187:1151.
46. Hunter, C. A., E. Candolfi, C. Subauste, V. Van Cleave, and J. S. Remington. 1995. Studies on the role of IL-12 in murine toxoplasmosis. Immunology 84:16.
47. Murphy, E., G. Terres, S. Macatonia, C.-S. Hsie, J. Mattson, L. Lanier, M. Wysocka, G. Trinchieri, K. Murphy, and A. O'Garra. 1994. B7 and interleukin 12 cooperate for proliferation and interferon-γ production by mouse T helper cell clones that are unresponsive to B7 costimulation. J. Exp. Med. 180:223.
48. Kubin, M., M. Kamoun, and G. Trinchieri. 1994. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production by human T cells. J. Exp. Med. 180:211.
49. McDyer, J. F., T. J. Goletz, E. Thomas, C. H. June, and R. A. Seder. 1998. CD40 ligand/CD40 stimulation regulates the production of IFN-γ from human peripheral blood mononuclear cells in an IL-12- and/or CD28-dependent manner. J. Immunol. 160:1701.
50. + T cells by costimulation with B7-2 molecules. J. Immunol. 160:1638.
51. Wu, C., R. R. Warrier, X. Wang, D. H. Presky, and M. K. Gately. 1997. Regulation of interleukin-12 receptor β1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells. Eur. J. Immunol. 27:147.
52. Lindsten, T., C. H. June, L. J. A., G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339.
53. Yang, Y., and J. M. Wilson. 1996. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 273:1862.
54. Grewal, I. S., H. G. Foellmer, K. D. Grewal, J. Xu, F. Hardardottir, J. L. Baron, C. A. Janeway, and R. A. Flavell. 1996. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273:1864.
55. Bennett, S. R. M., F. R. Caarbone, F. Karamalis, R. A. Flavell, J. F. A. P. Miller, and W. R. Heah. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature 393:478.
56. Schoenberger, S. P., R. E. M. Toes, E. I .H. van der Voort, R. Offringa, and C. J. M. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.
57. + T-helper and a T-killer cell. Nature 393: 474.
58. Zhou, P., and R. A. Seder. 1998. CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with Histoplasma capsulatum. J. Exp. Med. 187:1315.
59. Campos-Neto, A., P. Ovendale, T. Bement, T. A. Koppi, W. C. Fanslow, M. A. Rossi, and M. R. Alderson. 1998. CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis. J. Immunol. 160:2037.
60. Wiley, J. A., and A. G. Harmsen. 1995. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J. Immunol. 155:3525.
61. Cosyns, M., S. Tsirkin, M. Jones, R. A. Flavell, H. Kikutani, and A. R. Hayward. 1998. Requirement for CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice. Infect. Immun. 66:603.
62. + T cell interactions in IFN-γ and IL-4 responses to viral infections: requirements for IL-2. J. Immunol. 160:5007.
63. Boise, L. H., P. J. Noel, and C. B. Thompson. 1995. CD28 and apoptosis. Curr. Opin. Immunol. 7:620.